rebaudioside A/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Compared with placebo, rebaudioside A did not significantly alter resting, seated SBP, DBP, mean arterial pressure (MAP), heart rate (HR) or 24-h ambulatory blood pressures responses.”
Quoted verbatim from The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- 1000 mg/day rebaudioside A for 4 weeks
- Population
- healthy adults with normal and low-normal blood pressure
The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.2008PMID:18555574Permalink
Keep reading
- Everything the graph holds on rebaudioside A
- Every compound studied against Systolic blood pressure (setting unspecified)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PFDF9N94WJQVZX65CDHWWS